We have observed
10 EP applications
Sarah Elizabeth Klaczynska
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after September 25, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
RECOMBINANT SELF-REPLICATING POLYCISTRONIC RNA MOLECULES
IMMUNOGENIC COMBINATION COMPOSITIONS AND USES THEREOF
MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES
DELIVERY OF RNA TO TRIGGER MULTIPLE IMMUNE PATHWAYS
MENINGOCOCCAL FHBP POLYPEPTIDES
CHIMERIC, HYBRID AND TANDEM POLYPEPTIDES OF MENINGOCOCCAL NMB1870
P. AERUGINOSA PCRV-LINKED ANTIGEN VACCINES